Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PTC Therapeutics
Biotech
‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections
“The stories are so outrageous,” Sen. Johnson told Bloomberg about recent FDA rebuffs. “It just appears that they’re looking for excuses to say no.”
Gabrielle Masson
Mar 10, 2026 11:10am
FDA snubs PTC's Friedreich's ataxia hopeful with CRL
Aug 19, 2025 10:55am
PTC and Novartis’ Huntington's data fail to convince investors
May 6, 2025 7:25am
Novartis pays PTC $1B upfront for midphase Huntington's program
Dec 2, 2024 7:53am
PTC sells priority review voucher from Kebilidi nod for $150M
Nov 27, 2024 8:35am
PTC axes utreloxastat program after phase 2 ALS failure
Nov 27, 2024 4:45am
